Healthcare AI Exits Pilot Phase, Enters Production Deployment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as tech earnings spark AI spending worries and oil hits $100
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
BofA Securities on Doximity Inc (DOCS): 'No shift from DTC, but HCP growth is accelerating'
December 16, 2025 6:00 AM ESTBofA Securities analyst Allen Lutz reiterated a Buy rating and $82.00 price target on Doximity Inc (NYSE: DOCS).
The analyst comments "Yesterday, we hosted a conference call on pharma ad budgets with two industry executives, Andrew McLean, and Stuart Klein (bios below).... More
